Cooley

Sarah Buchik

Deals
3
Latest
May 2026
Most deals in
Biotech

Firm

  • Cooley Law firm · 2026 · 3 deals
Deals by year
Sarah Buchik: deals by year0320252026 YTD: 3 M&A32026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Sarah Buchik was named on, most recent first
May 2026 Curevo Vaccine –Eli LillyAcquisitionLegal adviser to Curevo Vaccine (target)Pending1,500.0Biotech+1Eli Lilly acquisition of Curevo Vaccine
Apr 2026 Ajax Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Ajax Therapeutics (target)Announced2,300.0Biotech+2Eli Lilly and Company acquisition of Ajax Therapeutics
Jan 2026 Alma –Spring HealthAcquisitionLegal adviser to Spring Health (acquirer)Announced–Healthcare Software+1Spring Health acquisition of Alma

Deals where Sarah Buchik is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.